Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Summary

This study is designed to demonstrate the long-term safety of vildagliptin in patients with type 2 diabetes. This study will study vildagliptin as add-on therapy with metformin, thiazolidinedione, α-glucosidase inhibitor (α-GI), rapid-acting insulin secretagogues in the treatment of type 2 diabetes in Japan.

Timeline

Start

2010-06

Primary completion

2012-01

Completion

2012-01

Drugs

Indications